Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs Wayne, PA, June...

Boehringer Ingelheim and Eli Lilly's Jardiance is chasing the FDA's blessing in chronic heart failure. (Boehringer Ingelheim) When Boehringer Ingelheim and Eli L...

Minerva Neurosciences is developing seltorexant with Janssen as an add-on treatment for major depressive disorder and insomnia disorder. (alex-mit/iStock/Getty Imag...

A combination of Cotellic and Tecentriq failed to beat Keytruda monotherapy in newly diagnosed patients with non-mutated melanoma in a Phase 3 trial, according to an...

Regeneron and Sanofi said Friday their experimental IL-33 antibody improved asthma control better than placebo in a Phase 2 study.But REGN3500 didn't beat the two dr...

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in t...

The Food and Drug Administration has lifted a clinical hold on one multiple myeloma trial for AbbVie's Venclexta after making several changes to the study protocols,...